Zoekresultaten - You searched for Diagnostics

171 results

PharmaFluidics raises 7.3 million euro to expand commercialization of novel micro-chip device for biomarker, diagnostics and drug development applications

Read more

MyCartis to spin out point-of-need diagnostics business in new company ANTELOPE Dx.

Read more

Belgian PCR interpretation software company UgenTec partners with multiplex molecular diagnostics innovator PathoFinder

Read more

Biocartis Group NV: Biocartis Q1 2017 Business Update

Read more

Biocartis Group NV: Biocartis announces its new CEO

Read more

Biocartis Group NV: MRC Technology and Biocartis initiate development of liquid biopsy test for breast cancer

Read more

Biocartis Group NV: Biocartis and A*STAR's ETPL initiate development of breast cancer assay to guide therapy selection

Read more

Biocartis Group NV: Idylla(TM) Respiratory (IFV-RSV) Panel receives 510(k) clearance by US FDA

Read more

Biocartis announces H1 2017 results

Read more

Genomic Health and Biocartis Announce Agreement to Develop an Idylla(TM) IVD Oncotype DX® Breast Cancer Test to Broaden Global Patient Access

Read more

Biocartis Group NV: BIOCARTIS Q3 2017 BUSINESS UPDATE

Read more

Biocartis announces 2017 results and 2018 outlook

Read more

Biocartis Selected for Oral Presentation at Cancer Research Meeting

Read more

Biocartis Group NV: Biocartis announces publication of its 2017 annual report

Read more

Biocartis Q1 2018 business update

Read more

Biocartis: Results of the annual shareholders' meeting held on 11 May 2018

Read more

Biocartis and Wondfo Announce Joint Venture for Commercialization of Idylla(TM) Platform in China

Read more

Biocartis Group NV: Genomic Health and Biocartis Expand Collaboration to Urology with the Development of an Idylla(TM) Oncotype DX Genomic Prostate Score® Test

Read more

Biocartis Group NV: Biocartis and Nichirei Bioscience Announce Commercialization Collaboration for Japanese Market

Read more

Novosanis enters into distribution deal with Fujirebio

Read more

Study on Performance Data of Idylla™ NRAS-BRAF Mutation Assay at 71st AACC Annual Scientific Meeting in Anaheim, CA (US)

Read more

Biocartis Group NV: Biocartis establishes US subsidiary and appoints US General Manager

Read more

MDxHealth and Maastricht University Collaborate on Next Generation (Epi)genetic Cancer Diagnostics

Read more

UgenTec and MDxHealth sign partnership agreement for software to support interpretation of molecular test results

Read more

UgenTec: announcing our $ 9.3 million Series A funding

Read more

UgenTec opens US sales office

Read more

Qarad nominated twice for TOPRA Awards

Read more

MDxHealth Reports Half Year 2019 Financial Results and Strategic Update

Read more

The Future of Health Technology: Lab on Chip & Diagnostics platform meeting

Read more

Biocartis Group NV: Disclosure of a transparency notification

Read more

Biocartis Group NV: Results of the annual shareholders' meeting held on 12 May 2017

Read more

Multiplicom launches complete CE-IVD marked solution in Europe for all BRCA testing needs

Read more

Biocartis Group NV: Study demonstrating high performance of Idylla(TM) liquid biopsy RAS tests to be presented at ASCO Annual Meeting

Read more

Biocartis Group NV: Biocartis launches CE-marked IVD NRAS test for colorectal cancer

Read more

Innovative software Moon autonomously diagnoses rare diseases within minutes

Read more

Biocartis Group NV: Biocartis' Idylla(TM) Instrument and Idylla(TM) Console exempt from US FDA 510(k) notification requirements

Read more

Biocartis Group NV: Strong performance data of proprietary MSI Biomarkers for the Idylla(TM) MSI Test to be published at ESMO

Read more

Biocartis Group NV: Biocartis announces 2017 half-year results on 7 September 2017

Read more

Biocartis Group NV: Results of the extraordinary shareholders' meeting held on 11 September 2017

Read more

R-Biopharm AG & UgenTec partner to develop software for automated PCR analysis

Read more

flanders.bio - Janssen Pharma Partner Day 2018: Innovate – Connect – Collaborate!

Read more

Dutch Life Sciences conference

Read more

Biocartis Group NV: Disclosure of outstanding voting securities

Read more

Biocartis Group NV: Idylla(TM) Performance Data Presented by US Key Opinion Leaders at Association for Molecular Pathology 2017 Conference

Read more

Biocartis launches CE-marked IVD RAS liquid biopsy tests developed under partnership with Merck KGaA, Darmstadt, Germany

Read more

Biocartis successfully raises EUR 80 million in an equity placement

Read more

Biocartis and Amgen Sign Companion Diagnostic Agreement for Idylla(TM) RAS Biomarker Tests

Read more

MedFIT - Fostering Innovation in medTech

Read more

Biocartis and Amgen Sign New Companion Diagnostic Agreement for Novel Oncology Compound

Read more

Biocartis - Disclosure of a transparency notification

Read more

Biocartis & Immunexpress Sign Partnership for a Sepsis Host Immune Response Test on the Idylla(TM) platform

Read more

Disclosure of a transparency notification

Read more

European Union provides Biocartis with up to EUR 24m debt financing facility for infectious disease projects

Read more

Biocartis Establishes R&D Center in the US

Read more

Biocartis: Two Performance Studies on Idylla(TM) MSI Biomarkers Selected for Publication at ASCO Conference

Read more

Biocartis Group NV: Study Demonstrates Ability of Idylla(TM) EGFR Mutation Test to Produce a Result in 80% of Failed Next Generation Sequencing Lung Cancer Tests

Read more

Biocartis Group NV: Study Reviewing 2,500 Performed Idylla(TM) Tests Shows Generation of Valid Results in 98.1% of Cases and Outperformance over Reference Methods

Read more

Biocartis launches innovative Idylla(TM) MSI Assay

Read more

Biocartis Group NV: Study Abstract on Performance of Idylla(TM) RAS tests Selected for Oral Presentation at 70th AACC Annual Scientific Meeting in Chicago, IL (US)

Read more

Biocartis Obtains Exclusive Worldwide License Rights for EGFR Ectodomain Mutations Determining Response

Read more

Biocartis Creates New Warrant Plan

Read more

PharmaFluidics Facilitates Ultra-high-resolution Proteomics Analysis Through Agreement with Thermo Fisher Scientific

Read more

Biocartis Group NV: Disclosure of outstanding voting securities

Read more

Biocartis Group NV: Studies on Idylla(TM) MSI and RAS liquid biopsy tests to be presented at ESMO congress

Read more

Novosanis Colli-Pee approved by Mexican health authority

Read more

Biocartis and AstraZeneca Enter Into Agreement Aimed at Faster Lung Cancer Biomarker Results

Read more

Novosanis acquired by Orasure Technologies Inc

Read more

Biocartis successfully raises EUR 55.50 million

Read more

Biocartis Places Its 1,000th Idylla(TM) Instrument with Geisinger in US

Read more

Biocartis Group NV: Biocartis announces CE-IVD marking of its Idylla(TM) MSI Test

Read more

Biocartis Group NV: Biocartis and Bristol-Myers Squibb Sign Collaboration Agreement for MSI Testing with Immuno-Oncology Therapies

Read more

Biocartis Group NV: Biocartis Announces Global Collaboration with Covance

Read more

Idylla(TM) MSI Performance Study Selected for Publication at ASCO Conference

Read more

Biocartis and Kite Sign Agreement for Development of Assays supporting Kite's Therapies

Read more

Invitation to the Special Shareholders’ Meeting

Read more

BIOCARTIS announces 2019 half-year results on 5 september 2019

Read more

Biocartis present at investor event VFB Happening this Saturday 25 March, Antwerp, BE

Read more

MDxHealth Epigenetic Biomarkers Identify Men at Increased Risk of Prostate Cancer Recurrence

Read more

Biocartis Group NV: Biocartis announces publication of 2016 Annual Report

Read more

Bootcamp in Entrepreneurial Innovation in Orphan Diseases

Read more

MDxHealth Trading Update: January to April 2017

Read more

Market of 105 billion euros open to Flemish biotech companies

Read more

Biocartis wins prestigious Galenus Prize with its Idylla(TM) NRAS-BRAF Mutation Test for colorectal cancer

Read more

Biocartis launches CE-marked IVD test for lung cancer

Read more

Biocartis Group NV: Disclosure of a transparency notification

Read more

MDxHealth and Queensland University of Technology Collaborate on Oral Cancer Liquid Biopsy Test

Read more

The annual CRIG industrial partnering event

Read more

MDxHealth Appoints Seasoned EVP to Lead Sales Force Expansion

Read more

UgenTec receives €50.000 grant by European Union

Read more

SelectMDx Outperforms PCA3 Stratifying Men for mpMRI

Read more

MDxHealth Announces Lowering of 2017 Guidance

Read more

MDxHealth financial results

Read more

MDxHealth contract SelectMDx with Roman Hospital

Read more

MDxHealth (R): SelectMDx Liquid Biopsy Test for Prostate Cancer included in the 2018 European Association Urology Guidelines

Read more

MDxHealth's New Share Capital Amount and New Number of Shares

Read more

MDxHealth Shareholder Transparency Declaration

Read more

MDxHealth Shareholder Transparency Declaration

Read more

MDxHealth (R): SelectMDx Included in Dutch DRG Reimbursement System

Read more

MDxHealth releases 2017 Annual Report

Read more

Imec demonstrates direct optical reading of single-molecule DNA bases in modified nanopores

Read more

Biogazelle appoints Armin Winands as new CEO

Read more

SelectMDx Cost-effective in Four European Countries

Read more

UgenTec to extend its software portfolio with FastTyper, a platform used for high-throughput SNP genotyping by end-point PCR

Read more

MyCartis to engage in point-of-need testing with the ANTELOPE Dx platform technology

Read more

MDxHealth Appoints Michael K. McGarrity as CEO

Read more

Agilent reikt Thought Leader Award uit aan

Read more

Fluidda and Materialise announce partnership to develop personalized solutions for lung patients

Read more

Bootcamp in Rare Diseases

Read more

Brain imaging AI leader icometrix raises $18 million in new funding

Read more

MDxHealth (R): Multi-center Study Validates SelectMDx's High Negative Predictive Value and Sensitivity

Read more

AI4Diag

Read more

MDxHealth Announces Favorable Draft Medicare Coverage for the SelectMDx Test

Read more

Novosanis signs an agreement to provide MDxHealth a customized urine collection device

Read more

Symposium on Sepsis

Read more

Biogazelle offers unique mRNA sequencing on plasma

Read more

Mithra to Initiate PK Study for Estelle®

Read more

SLims by Genohm integrated with Pathomation’s PMA.core

Read more

ViroVet and GALVmed to collaborate on novel vaccines for sheep & goats

Read more

Daily Newsflash- 7/06/2017

Read more

Services

Read more

Mithra Signs Exclusive License and Supply Agreement with Fuji Pharma for Donesta® in Japan and Asean

Read more

Membership Information

Read more

MVZ Dr. Stein & Kollegen First German Medical Laboratory to Offer the SelectMDx for Prostate Cancer Test

Read more

PharmaFluidics appoints Fasha Mahjoor as independent director

Read more

Expertise - FUND

Read more

Life sciences meets micro-nanoelectronics: zooming in on MEDICAL DEVICES

Read more

Biotech Showcase™ 2018

Read more

BioFIT 2017

Read more

Life Sciences Baltics 2018

Read more

MDxhealth teams up with Pharmaceutical Company Ferrer for distribution of its Prostate Cancer test SelectMDx in Spain

Read more

Medical Biotechnology

Read more

Trainings - 19/12/2017

Read more

Make your perfect pitch for Life Sciences investors

Read more

Trainings - 15/01/2018

Read more

BARC and Biogazelle announce collaboration for advanced genetic testing in clinical trials

Read more

Networking - 01/03/2018

Read more

Press Release - Life Sciences & Biotechnology - 2/02/2018

Read more

Colli-Pee recognized at the prestigious Henry Van de Velde Awards

Read more

new England biolabs® and Bluebee partner to deliver an end-to-end data analysis solution for Nebnext direct® target enrichment

Read more

Research and innovation on monitoring and control of infectious diseases (One Health)

Read more

Novosanis’ medical device Colli-Pee® prefilled with urine preservative now CE-certified

Read more

Press Release - Life Sciences & Biotechnology - 30/03/2018

Read more

Hamilton Robotics first company to join the UgenTec’s new Molecular Automation Network

Read more

Agilent Technologies to Enhance Lab Informatics with Acquisition of Genohm

Read more

Novosanis obtains regulatory approval for Colli-Pee in Brazil

Read more

Press Release - Life Sciences & Biotechnology - 26/07/2018

Read more

V-Bio Ventures participates in 22.5 million euros series B financing round of HORAMA

Read more

V-Bio Ventures leads Camel-IDS EUR 37m Series A financing to develop cancer targeted radiopharmaceuticals

Read more

Biotech Showcase™ 2019

Read more

Pharmafluidics’ new product launch steers ‘on-a-chip’ separations of complex biological samples to new heights

Read more

V-Bio Ventures leads AgomAb Therapeutics’ 21m EUR series A financing round

Read more

PMV is stepping into a strategic partnership with flanders.bio as of June 1st, 2019

Read more

flanders.bio provides you with insights in the vibrant life sciences sector

Read more

PwC Scale: Life Sciences

Read more

Evénement annuel bio.be/essenscia: Evidence-based biotechnologies: the future is in (y)our hands

Read more

Fast Track Diagnostics and UgenTec announce new interpretation software for all FTD real-time PCR multiplex kits

Read more

flanders.bio - Roche Diagnostics Partner Day 2018: ’Towards high-quality Cell Therapy’

Read more

Thank you for attending the latest flanders.bio - Roche Diagnostics Partner Day

Read more

OPINNO educational module: What does it take to work in a life sciences company?

Read more

MDxhealth Enters into Distribution Agreement with Unilabs for SelectMDx for Prostate Cancer

Read more

Ablynx appoints Markus Ewert as Chief Business Officer

Read more

flanders.bio strenghtens its team with the appointment of 3 Programme Managers

Read more

UgenTec Announces partnership with Serosep Ltd.

Read more

5 Flemish universities reveal innovative state-of-the-art biotech research at knowledge for growth 2019

Read more

Bionection

Read more

Networking - 14/06/2018

Read more

Trainings - EDUCATE

Read more

Flanders @ BIO-Europe 2017

Read more

Follow-up info flanders.bio-CMAST Partner Day

Read more

7/12/2017

Read more

Expertise

Read more